BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 21041563)

  • 1. An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes.
    Slatore CG; Au DH; Gould MK;
    Am J Respir Crit Care Med; 2010 Nov; 182(9):1195-205. PubMed ID: 21041563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in Systemic Treatment Use in Advanced-stage Non-Small Cell Lung Cancer by Source of Health Insurance.
    Maguire FB; Morris CR; Parikh-Patel A; Cress RD; Keegan THM; Li CS; Lin PS; Kizer KW
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1059-1066. PubMed ID: 30842132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access denied: The relationship between patient insurance status and access to high-volume hospitals.
    Nabi J; Tully KH; Cole AP; Marchese M; Cone EB; Melnitchouk N; Kibel AS; Trinh QD
    Cancer; 2021 Feb; 127(4):577-585. PubMed ID: 33084023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuous insurance coverage predicts prolonged hospital stay after pediatric adenotonsillectomy.
    Tumin D; King A; Walia H; Tobias JD; Raman VT
    J Surg Res; 2017 Oct; 218():86-91. PubMed ID: 28985881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment variation by insurance status for breast cancer patients.
    Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
    Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
    Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
    J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access and Quality of Care by Insurance Type for Low-Income Adults Before the Affordable Care Act.
    Nguyen KH; Sommers BD
    Am J Public Health; 2016 Aug; 106(8):1409-15. PubMed ID: 27196646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Insurance Type at Diagnosis and Hepatocellular Carcinoma Survival.
    Adler Jaffe S; Myers O; Meisner ALW; Wiggins CL; Hill DA; McDougall JA
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):300-307. PubMed ID: 31796525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of insurance status on access to and utilization of a tertiary hand surgery referral center.
    Calfee RP; Shah CM; Canham CD; Wong AH; Gelberman RH; Goldfarb CA
    J Bone Joint Surg Am; 2012 Dec; 94(23):2177-84. PubMed ID: 23224388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between insurance status and interhospital transfers among cancer patients in the United States.
    Rubens M; Ramamoorthy V; Saxena A; Appunni S; Sundil S; Veledar E; McGranaghan P; Tonse R; Fitz SJT; Chuong MD; Odia Y; Kotecha R; Mehta MP; Kotecha R
    BMC Cancer; 2022 Jan; 22(1):121. PubMed ID: 35093015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of health insurance on childhood cancer survival in the United States.
    Lee JM; Wang X; Ojha RP; Johnson KJ
    Cancer; 2017 Dec; 123(24):4878-4885. PubMed ID: 28891067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement.
    Rivera MP; Katki HA; Tanner NT; Triplette M; Sakoda LC; Wiener RS; Cardarelli R; Carter-Harris L; Crothers K; Fathi JT; Ford ME; Smith R; Winn RA; Wisnivesky JP; Henderson LM; Aldrich MC
    Am J Respir Crit Care Med; 2020 Oct; 202(7):e95-e112. PubMed ID: 33000953
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
    Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
    Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.
    Fletcher SA; Cole AP; Lu C; Marchese M; Krimphove MJ; Friedlander DF; Mossanen M; Kilbridge KL; Kibel AS; Trinh QD
    Cancer; 2020 Feb; 126(3):496-505. PubMed ID: 31626340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of payer status on survival in parotid malignancy.
    Stubbs VC; Rajasekaran K; Chen J; Cannady SB; Brant JA; Newman JG
    Am J Otolaryngol; 2019; 40(4):555-559. PubMed ID: 31097206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not All Insurance Is Equal: Differential Treatment and Health Outcomes by Insurance Coverage Among Nonelderly Adult Patients With Heart Attack.
    Niedzwiecki MJ; Hsia RY; Shen YC
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29871858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.
    Rice SR; Vyfhuis MAL; Scilla KA; Burrows WM; Bhooshan N; Suntharalingam M; Edelman MJ; Feliciano J; Badiyan SN; Simone CB; Bentzen SM; Feigenberg SJ; Mohindra P
    Clin Lung Cancer; 2020 May; 21(3):e130-e141. PubMed ID: 31708388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of demographics, socioeconomics, and health care access on melanoma outcomes.
    Cortez JL; Vasquez J; Wei ML
    J Am Acad Dermatol; 2021 Jun; 84(6):1677-1683. PubMed ID: 32783908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.
    Markt SC; Lago-Hernandez CA; Miller RE; Mahal BA; Bernard B; Albiges L; Frazier LA; Beard CJ; Wright AA; Sweeney CJ
    Cancer; 2016 Oct; 122(20):3127-3135. PubMed ID: 27500561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer.
    Wu J; Huang Y; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Hershman DL; Wright JD
    Gynecol Oncol; 2020 Nov; 159(2):309-316. PubMed ID: 32800656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.